Stem Cells Inc. Posts Letter to Shareholders – Benzinga
|
Stem Cells Inc. Posts Letter to Shareholders
Benzinga Our journey began in 2000, when scientists at StemCells, Inc. were able to purify the expandable population of human neural stem cells that became our HuCNS-SC platform technology. When formulated for transplantation, HuCNS-SC cells maintain their … |
